US Commodity Futures Commission (CFTC) Chairman Classifies 6 Cryptocurrencies as Digital Commodities! Here Are the Details

According to Wu Blockchain, Selig, while explaining the crypto asset classification jointly developed by the CFTC and the U.S. Securities and Exchange Commission (SEC), presented these six crypto assets as examples of digital commodity categories.

Selig’s remarks are noteworthy in the context of efforts to create a more detailed framework for the regulatory status of crypto assets in the US. The CFTC Chair stated that the institution plans to differentiate between various activities and asset types, rather than classifying the entire crypto market under a single category.

In this context, the CFTC is expected to develop more specific rules for areas such as digital commodities, retail crypto transactions, and physical delivery conducted on the blockchain.

Selig also stated that wallets that do not offer custody services and software developers should be treated separately within the regulatory framework. The aim is to differentiate between organizations that directly hold assets or provide trading services and those that only develop software.

The CFTC’s approach is based on classifying different activities within the crypto ecosystem according to their function, rather than subjecting them to the same regulatory standards.

Selig’s inclusion of BTC, ETH, SOL, XLM, XTZ, and XRP as examples of digital commodities also stands out as a key element of the more detailed crypto asset classification that the institution is preparing.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53